Pleasanton, CA, United States of America

Phillip Belgrader

USPTO Granted Patents = 122 (Patent Applications = 46)

CIPO Patents = 4 (Patent Applications = 8)

EPO Patents = 16 (Patent Applications = 20)

Average Co-Inventor Count = 4.0

ph-index = 27

Forward Citations = 2,981(Granted Patents)

Forward Citations (Not Self Cited) = 2,804(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Serverna Park, MD (US) (2012)
Manteca, CA (US) (2000 - 2018)
Severna Park, MD (US) (2006 - 2022)
Livermore, CA (US) (2013 - 2024)
Pleasanton, CA (US) (2019 - 2024)

Company Filing History:

Akonni Biosystems, Inc.

Bio-rad Laboratories, Inc.

patents

6. 3 out of 1,521

Cornell Research Foundation Inc.

patents

7. 2 out of 15,488

University of California

patents

8. 2 out of 15

Microfluidic Systems, Inc.

patents

9. 1 out of 817

Louisiana State University and Agricultural & Mechanical College

patents

10. 1 out of 2,310

University of Minnesota

patents

11. 2 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2024

Loading Chart...

Areas of Expertise:

Nucleic Acid Editing

Automated Cell Processing

Polynucleotide Processing

Genetic Material Detection

Nuclease Editing

Electroporation Modules

Magnetic Lysis

Cell Growth Control

Viral Delivery Systems

Reagent Cartridges

Live Cell Detection

Nucleic Acid Assembly

122 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162008 - Partition-based method of analysis (2024-12-10),

2. 12110549 - Methods and systems for processing polynucleotides (2024-10-08),

3. 12097495 - Methods and compositions for detecting genetic material (2024-09-24),

4. 12084716 - Methods and systems for processing polynucleotides (2024-09-10),

5. 11965154 - Detection of nuclease edited sequences in automated modules and instruments (2024-04-23),

6. 11845932 - Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery (2023-12-19),

7. 11767549 - Integrated sample processing system (2023-09-26),

8. 11739290 - Instruments, modules, and methods for improved detection of edited sequences in live cells (2023-08-29),

9. 11732302 - Methods and systems for processing polynucleotides (2023-08-22),

10. 11685889 - Detection of nuclease edited sequences in automated modules and instruments (2023-06-27),

11. 11603554 - Partition processing methods and systems (2023-03-14),

12. 11597921 - Automated cell processing methods, modules, instruments, and systems (2023-03-07),

13. 11591592 - Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers (2023-02-28),

14. 11499181 - Analysis of nucleic acids (2022-11-15),

15. 11407994 - Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery (2022-08-09),

Title: Inventor Phillip Belgrader: Pioneering Innovations in Pleasanton

Introduction: Phillip Belgrader is a renowned inventor based in Pleasanton, California, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Belgrader holds several patents in diverse areas, showcasing his versatility and creativity in inventing new solutions to existing problems.

Career Highlights: Throughout his illustrious career, Phillip Belgrader has consistently pushed the boundaries of innovation, with his inventions making a significant impact in industries such as technology, healthcare, and sustainability.

Collaborations: Belgrader has collaborated with leading companies, research institutions, and universities to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Phillip Belgrader's passion for innovation and his dedication to creating meaningful change through his inventions have solidified his reputation as a pioneering inventor in Pleasanton and beyond.

This text is generated by artificial intelligence and may not be accurate.